|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 350-354, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
CG McGregor, JH Dark, CJ Hilton, R Freeman, ID Conacher and PA Corris
Three patients underwent single left lung transplantation for end-stage
pulmonary fibrosis between June and November 1987. Preoperatively all were
housebound, receiving continuous, supplemental oxygen, and their pulmonary
function had deteriorated despite corticosteroid and cyclophosphamide
therapy. Pulmonary preservation was by means of pulmonary arterial
perfusion with modified Euro-Collins solution, 60 ml/kg, at 4 degrees C
with adjunctive iloprost (synthetic prostacyclin) infusion. The heart from
each donor was used successfully for transplantation. Good early graft
function enabled extubation 11, 46, and 96 hours after transplantation. An
omental wrap was used around the bronchial anastomosis, and bronchial
healing was satisfactory in all. All patients had episodes of pulmonary
rejection diagnosed by a combination of symptoms, chest x-ray infiltrates,
the exclusion of pneumonitis by bronchoalveolar lavage, and prompt response
to "pulse" steroid therapy. Two of the three patients had three episodes of
opportunistic pulmonary infections: Herpes simplex pneumonitis,
Pneumocystis carinii infection, and Aspergillus pneumonitis. The three
patients were discharged from the hospital after 5, 6, and 7 1/2 weeks,
respectively. The first and third patients remain alive and well, living
essentially normal lives 24 and 19 months after transplantation with no
evidence of arterial desaturation on exercise testing while breathing room
air. The second patient had symptoms of deteriorating lung function with a
progressive decline in forced expiratory volume in 1 second, vital
capacity, and diffusion capacity despite repeated "pulse" therapy with
combinations of methylprednisolone, antithymocyte globulin, and OKT3 (Ortho
Diagnostic Systems Inc., Raritan, N.J.). An open lung biopsy specimen
showed obliterative bronchiolitis, and this patient underwent orthotopic
lung retransplantation, on the right side. Despite excellent early graft
function and early extubation, he died of uncontrolled rejection and
general debility after 3 weeks. This early experience in our center with
two of three patients surviving 19 to 24 months, respectively, confirms the
restoration of good pulmonary function and near normal life-style in
patients with end-stage pulmonary fibrosis after single lung
transplantation, as first reported by the Toronto Lung Transplant Group. We
have used an alternative method of lung preservation (cold crystalloid
pulmonary perfusion as opposed to topical cooling, used by the Toronto
group), which provided excellent pulmonary preservation up to and beyond 4
hours' storage.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Early results of single lung transplantation in patients with end-stage pulmonary fibrosis
Freeman Hospital, Newcastle upon Tyne, England.
This article has been cited by other articles:
![]() |
M. Struber, J. M. Hohlfeld, T. Kofidis, G. Warnecke, J. Niedermeyer, S. P. Sommer, and A. Haverich Surfactant function in lung transplantation after 24 hours of ischemia: Advantage of retrograde flush perfusion for preservation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 98 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wittwer, T. Wahlers, J. F. Cornelius, S. Elki, and A. Haverich Celsior solution for improvement of currently used clinical standards of lung preservation in an ex vivo rat model Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 667 - 671. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |